Latest Leverage News

Citigold Corporation Limited reports steady progress in exploration and mine design at its Charters Towers Gold Project, while actively pursuing funding partnerships to restart operations.

Platina Resources reported steady progress across multiple Western Australian gold projects in the June 2025 quarter, balancing promising drill results with operational hurdles and a solid cash position.

Memphasys Limited has submitted its Felix™ sperm separation system for CE Mark approval, targeting Europe’s $5 billion IVF market, while expanding direct sales in Japan and validating its RoXsta™ oxidative stress diagnostic platform.

Stelar Metals has been granted a new exploration licence in South Australia targeting titanium-rich heavy mineral sands, while also uncovering promising tin potential at its New South Wales Trident Project.

KGL Resources has leveraged cutting-edge integrated 3D inversion modelling to reveal multiple high-priority exploration targets at its Jervois and Unca Creek tenements, suggesting a larger and deeper mineral system than previously known.

Ballymore Resources’ latest drilling at the Dittmer Project in North Queensland confirms expanding high-grade gold, silver, and copper mineralisation, with promising deep extensions identified. The company is advancing towards mining lease approval to unlock further underground exploration.

Uvre Limited has secured a transformative portfolio of New Zealand gold projects, including the high-grade Waitekauri asset, backed by a $4 million capital raise and new board appointments. The company is gearing up for its maiden drilling campaign this September.

Magnis Energy Technologies progresses detailed engineering on its Nachu Graphite Project and moves to fast track US anode material production, while navigating ASX suspension and IM3NY bankruptcy fallout.

Infini Resources has refined its geological model at the Portland Creek uranium project, identifying new high-priority targets for an August 2025 Phase 2 drilling campaign. Despite challenges in Phase 1, the company remains optimistic about unlocking a major discovery in Newfoundland.

Axel REE Limited reports encouraging first-stage metallurgical results from its Caladão Project, confirming recoveries of valuable rare earth elements and gallium using cost-effective leaching methods.

Cynata Therapeutics is advancing three pivotal clinical trials targeting acute Graft versus Host Disease, osteoarthritis, and kidney transplantation, with major results expected through early 2026. The company maintains a solid cash position supporting its clinical pipeline and strategic growth.

Westar Resources’ June quarter report reveals intriguing molybdenum, bismuth, and tungsten anomalies at its Mageye prospect, prompting a strategic review of exploration plans amid a solid $1.2 million cash position.